BR0115106A - métodos para a preparação de tecido bioprotético e dispositivos implantáveis compreendendo tal tecido bioprotético - Google Patents

métodos para a preparação de tecido bioprotético e dispositivos implantáveis compreendendo tal tecido bioprotético

Info

Publication number
BR0115106A
BR0115106A BRPI0115106-1A BR0115106A BR0115106A BR 0115106 A BR0115106 A BR 0115106A BR 0115106 A BR0115106 A BR 0115106A BR 0115106 A BR0115106 A BR 0115106A
Authority
BR
Brazil
Prior art keywords
methods
tissue
bioprosthetic tissue
preparing
implantable devices
Prior art date
Application number
BRPI0115106-1A
Other languages
English (en)
Inventor
Crystal Cunanan
Tan Dinh
Chris H Sarner
Michael N Helmus
Christine Cabling
Christine Loshbaugh
Original Assignee
Edwards Lifesciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/930,619 external-priority patent/US20030050276A1/en
Application filed by Edwards Lifesciences Corp filed Critical Edwards Lifesciences Corp
Publication of BR0115106A publication Critical patent/BR0115106A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"MéTODOS PARA A PREPARAçãO DE TECIDO BIOPROTéTICO E DISPOSITIVOS IMPLANTáVEIS COMPREENDENDO TAL TECIDO BIOPROTéTICO". A presente invenção refere-se a métodos de inativação e remoção de agentes infecciosos de tecidos de uso em dispositivos bioprotéticos. Os métodos incluem remoção e bloqueio de sítios de ligação prra os agentes infecciosos sobre os tecidos. Também são proporcionados métodos para bloqueio de um sítio sobre um agente infeccioso que se liga a um sítio sobre o tecido. A invenção também proporciona um método para conservação ou redução da calcificação de um tecido bioprotético. O método inclui remoção ou bloqueio de um sítio de nucleação de cálcio de fosfolipídio no tecido.
BRPI0115106-1A 2000-11-01 2001-11-01 métodos para a preparação de tecido bioprotético e dispositivos implantáveis compreendendo tal tecido bioprotético BR0115106A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24488900P 2000-11-01 2000-11-01
US09/930,619 US20030050276A1 (en) 2001-08-15 2001-08-15 Treatment of tissue, instruments and work surfaces to remove infectious agents
PCT/US2001/046088 WO2002043778A2 (en) 2000-11-01 2001-11-01 Methods for preparation of bioprosthetic tissue and implantable devices comprising such bioprosthetic tissue

Publications (1)

Publication Number Publication Date
BR0115106A true BR0115106A (pt) 2006-02-21

Family

ID=26936865

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0115106-1A BR0115106A (pt) 2000-11-01 2001-11-01 métodos para a preparação de tecido bioprotético e dispositivos implantáveis compreendendo tal tecido bioprotético

Country Status (6)

Country Link
US (1) US20020137024A1 (pt)
EP (1) EP1335751A2 (pt)
AU (1) AU2002241573A1 (pt)
BR (1) BR0115106A (pt)
CA (1) CA2427165A1 (pt)
WO (1) WO2002043778A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003249272A1 (en) * 2002-07-16 2004-02-02 Edwards Lifesciences Corporation Enhanced phospholipid reduction and calcification mitigation of biological materials
EP1464334A1 (de) * 2003-04-03 2004-10-06 Fluka GmbH Dekontaminationsmittel gegen Prionen
US20060110370A1 (en) * 2004-11-23 2006-05-25 Pathak Chandrashenkhar P Treatments for reduction of cytotoxicity and viral contamination of implantable medical devices
US7989157B2 (en) * 2005-01-11 2011-08-02 Medtronic, Inc. Solution for storing bioprosthetic tissue used in a biological prosthesis
EP2798057B1 (en) * 2011-12-30 2018-08-22 Vivex Biomedical, Inc. Regenerative tissue matrix
EP3366324A1 (en) 2017-02-22 2018-08-29 Epygon Product and method for the treatment of bioprosthetic tissues
CN108675356B (zh) * 2018-05-30 2021-04-30 博瑞生物医药（苏州）股份有限公司 超顺磁氧化铁内毒素的去除方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729139A (en) * 1985-11-05 1988-03-08 Baxter Travenol Selective incorporation of a polymer into implantable biological tissue to inhibit calcification
US6121041A (en) * 1996-07-31 2000-09-19 St. Jude Medical, Inc. Use of microorganisms for decellularizing bioprosthetic tissue
US6008292A (en) * 1997-12-02 1999-12-28 Baxter International Inc. Method for inhibiting calcification of aldehyde-fixed bioprosthetic materials

Also Published As

Publication number Publication date
WO2002043778A3 (en) 2003-02-27
EP1335751A2 (en) 2003-08-20
US20020137024A1 (en) 2002-09-26
WO2002043778A2 (en) 2002-06-06
AU2002241573A1 (en) 2002-06-11
CA2427165A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
ES2121793T3 (es) Composiciones de uso local para la administracion transdermica de derivados profarmacos de morfina.
BR0115323A (pt) Uso de cci-779 como agente antineoplástico
BR0109729A (pt) Uso de uma combinação de um agente anti-angiogênico e um agente anti-hipertensivo, kit para uso na produção de um efeito anti-angiogênico e/ou efeito redutor da permeabilidade vascular em um animal de sangue quente, e, método de tratamento de um estado doentio associado com a angiogênese
DK1140212T3 (da) Målrettet anvendelse af radium 223 mod kalkholdigt væv til lettelse af smerter ved behandling af knoglekræft
CO4970701A1 (es) Metodo para mantener y/o mejorar la salud de la piel de un usuario en el area cubierta por un articulo absorbente
ES2183186T3 (es) Composiciones cosmeticas en polvo que contienen elastomeros de silicona.
BR9913351A (pt) Artigos absorventes descartáveis com adesivo aperfeiçoado para acoplamento à pele
DE69721766D1 (de) Neue arzneiformulierung
ATE449581T1 (de) System zur minimalinvasiven einführung einer herzklappen- bioprothese
ATE222759T1 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
ES2162029T3 (es) Composiciones para el cuidado personal y productos de paños de frotar que contienen a las composiciones.
BR9915008A (pt) Composição de xampu, e, processo para preparação da mesma
BR9813961A (pt) Metodo para remover sais biliares de um paciente, polimero de polidialilamina e seus sais, e seu uso.
SE9404196D0 (sv) New antithrombotic formulation
BR0316203A (pt) Uso de um agente antialérgico e um esteróide para tratar rinite alérgica
ATE279910T1 (de) Tensid für äusserlich anzuwendende hautpräparate und diese beinhaltende äusserlich anzuwendende hautpräparate
BR0113751A (pt) Composições cosméticas e farmacêuticas e seus empregos
BR0010531A (pt) Composições e usos de et743 para tratamento de câncer
BR0107667A (pt) Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo
BR0011225A (pt) Agente para tratar de olhos secos, seu método e uso
GB9807298D0 (en) Medicament
BR0115106A (pt) métodos para a preparação de tecido bioprotético e dispositivos implantáveis compreendendo tal tecido bioprotético
BR9811298A (pt) Uso de um composto de vanádio fisiologicamente aceitável
AR023271A1 (es) Conjugado polimerico capaz de inhibir una o mas enzimas proteoliticas
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2021 DE 29/09/2009.